Not checked for notices yet.
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
Saul J. Priceman, Ethan A. Gerdts, Dileshni Tilakawardane and 15 more
OncoImmunology · 2018
doi:10.1080/2162402x.2017.1380764
Cited by papers we hold 5
- PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial · 2024No notice
- Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting · 2023No notice
- Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating · 2023No notice
- CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment · 2019No notice
- Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells · 2018No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.